argenx SE News

Piper Sandler Sticks to Its Buy Rating for Argenx Se (ARGX)

TipRanksApr 26 07:50 ET

Analysts' Top Healthcare Picks: Elevance Health (ELV), Argenx Se (ARGX)

TipRanksApr 19 05:50 ET

Jefferies Urges Deeper Dive Into Mid-caps, Picks 12 Ideas Including GTA-publisher Take-Two

Seeking AlphaApr 18 17:13 ET

The Analyst Verdict: Argenx In The Eyes Of 12 Experts

Providing a diverse range of perspectives from bullish to bearish, 12 analysts have published ratings on argenx (NASDAQ:ARGX) in the last three months.The table below summarizes their recent ratings,

BenzingaApr 18 10:01 ET

Argenx Price Target Maintained With a $521.00/Share by Wedbush

Argenx Price Target Maintained With a $521.00/Share by Wedbush

Dow JonesApr 18 09:32 ET

Express News | HC Wainwright & Co. Reiterates Buy on Argenx, Maintains $451 Price Target

Moomoo 24/7Apr 18 06:41 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: IGM Biosciences (IGMS) and Argenx Se (ARGX)

TipRanksApr 18 06:30 ET

European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading

European equities traded in the US as American depositary receipts were trending lower Wednesday morning, falling 0.3% to 1,330.47 on the S&P Europe Select ADR Index. From continental Europe, the gain

MT NewswiresApr 17 11:10 ET

Argenx Data Highlight Evidence That VYVGART and VYVGART Hytrulo Drive Transformative Outcomes for Patients With Debilitating Autoimmune Disease

ADHERE data show VYVGART Hytrulo has potential to be first advancement for CIDP patients in 30 years Real-world data demonstrate gMG patients able to significantly reduce steroid use over first six months of

GlobeNewswireApr 16 01:00 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Argenx Se (ARGX), Neogen (NEOG) and Supernus Pharmaceuticals (SUPN)

TipRanksApr 15 07:10 ET

Argenx Se (ARGX) Receives a Buy From Bank of America Securities

TipRanksApr 12 09:36 ET

Cartesian Therapeutics' Rare Disease Candidate Shows Long Lasting Benefit Over Argenx's Vyvgart, Analyst Initiates With Buy

Needham initiated coverage on Cartesian Therapeutics Inc (NASDAQ:RNAC), a private company that went public in November following its reverse merger/ private placement financing with Selecta Bioscience

BenzingaApr 10 14:34 ET

European Equities Traded in the US as American Depositary Receipts Trend Higher in Thursday Trading

European equities traded in the US as American depositary receipts were trending higher Thursday morning, rising 0.69% to 1,386.14 on the S&P Europe Select ADR Index. From continental Europe, the gain

MT NewswiresApr 4 11:06 ET

UBS Reaffirms Their Hold Rating on Argenx Se (ARGX)

TipRanksApr 3 04:15 ET

Here's Why Argenx SE (ARGX) Pulled Back 23% in Q4

Yahoo FinanceMar 29 04:42 ET

Buy Rating Affirmed for Argenx Se on Efgartigimod Progress and Regulatory Success

TipRanksMar 29 03:09 ET

Analysts Offer Insights on Healthcare Companies: Moderna (MRNA), Argenx Se (ARGX) and NovoCure (NVCR)

TipRanksMar 28 05:01 ET

ArGEN-X Is Maintained at Buy by HC Wainwright & Co.

ArGEN-X Is Maintained at Buy by HC Wainwright & Co.

Dow JonesMar 27 11:00 ET

HC Wainwright & Co. Maintains Buy on Argenx, Maintains $451 Price Target

HC Wainwright & Co. analyst Douglas Tsao maintains argenx with a Buy and maintains $451 price target.

Analyst UpgradesMar 27 10:49 ET

Buy Rating Affirmed for Argenx Se on Strong Pipeline and Market Potential

TipRanksMar 27 10:45 ET